CBD products could be prescribed to British patients from as early as next month after the UK government announced plans to lift restrictions on the medical use of cannabis.
The change in policy follows recommendations from the Advisory Council on the Misuse of Drugs (ACMD) and the UK’s Chief Medical Adviser.
The new law will not limit the types of condition that can be considered for treatment with cannabis and cannabis-derivative products. Doctors will no longer need to seek approval from an expert panel in order for patients to access the medicines.
While CBD is not explicitly listed in the legislation, it is understood that it would fall under the umbrella of cannabis-derived medicines.
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sectors, with a focus on non-US markets. Most content is available to subscribers only.